06:42 AM EDT, 07/03/2024 (MT Newswires) -- Blackstone (BX) said Wednesday it has agreed to sell Alinamin Pharmaceutical to Japanese private equity firm MBK Partners.

No financial details were disclosed. But Reuters on Tuesday cited an unnamed source as saying the sale price for the Japanese supplement maker was 350 billion yen ($2.17 billion).

Upon the closing of the deal, Blackstone will re-invest an indirect, minority stake in Alinamin Pharmaceutical.

Price: 122.80, Change: -0.41, Percent Change: -0.33